Magnesium Chloride 1M Solution (Biotechnology Grade)

<strong>Magnesium Chloride 1M Solution (MgCl2)</strong>_x000D_ <table width="773">_x000D_ <tbody>_x000D_ <tr>_x000D_ <td width="140">Catalog number:</td>_x000D_ <td width="633">B2010036</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Lot number:</td>_x000D_ <td>Batch Dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Expiration date:</td>_x000D_ <td>Batch Dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Volume:</td>_x000D_ <td>10 x 1 mL</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Formula:</td>_x000D_ <td>MgCl₂</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>MW</td>_x000D_ <td>95.21 g/mol</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Appearance:</td>_x000D_ <td>Clear Solution</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Application:</td>_x000D_ <td>Buffer Formulation, PCR, Reagent Formulation, Enzymatic Activity Testing, Reagent Stabilization, Protein purification, in vitro replication, transcription, etc.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Shelf-Life</td>_x000D_ <td>Two years from date of manufacture</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Storage:</td>_x000D_ <td>Shipped at 2-8C. Store at -20C.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Keywords:</td>_x000D_ <td>magnesium chloride, Magnesium Chloride 1M</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Grade</td>_x000D_ <td>Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity <span class="ILfuVd"><span class="e24Kjd">&gt;18 MΩ-cm</span></span>) and are filtered on a 0.22 um.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>References</td>_x000D_ <td width="633">_x000D_ <ul>_x000D_ <li>Sheehan J. Importance of magnesium chloride repletion after myocardialinfarction. Am J Cardiol. 1989 Apr 18;63(14):35G-38G.</li>_x000D_ <li>Seelig M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion. Am J Cardiol. 1989 Apr 18;63(14):4G-21G.</li>_x000D_ <li>Durlach J, Bara M, Theophanides T. A hint on pharmacological and toxicological differences between magnesium chloride and magnesium sulphate of scallops and men. Magnes Res. 1996 Oct;9(3):217-9.</li>_x000D_ <li>Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 2001 Sep Oct;8(5):345-57.</li>_x000D_ <li>Nalos M, Asfar P, Ichai C, Radermacher P, Leverve XM, Fröba G. Adenosine triphosphate-magnesium chloride: relevance for intensive care. Intensive Care Med. 2003 Jan;29(1):10-8.</li>_x000D_ <li>Kelepouris E, Kasama R, Agus ZS. Effects of intracellular magnesium on calcium, potassium and chloride channels. Miner Electrolyte Metab. 1993;19(4-5):277-81.</li>_x000D_ <li>Oorschot DE. Cerebral palsy and experimental hypoxia-induced perinatal brain injury: is magnesium protective? Magnes Res. 2000 Dec;13(4):265-73.</li>_x000D_ <li>Caddell JL. Magnesium in perinatal care and infant health. Magnes Trace Elem. 1991-1992;10(2-4):229-50.</li>_x000D_ <li>Quamme GA. Renal handling of magnesium: drug and hormone interactions. Magnesium. 1986;5(5-6):248-72.</li>_x000D_ <li>Quamme GA, Dirks JH. The physiology of renal magnesium handling. Ren Physiol. 1986;9(5):257-69.</li>_x000D_ <li>Common stock solutions, buffers, and media. <a href="https://pubmed.ncbi.nlm.nih.gov/18228281/">Curr Protoc Cell Biol.</a> 2001 May; Appendix 2:Appendix 2A.</li>_x000D_ </ul>_x000D_ </td>_x000D_ </tr>_x000D_ </tbody>_x000D_ </table>_x000D_ <table width="773">_x000D_ <tbody>_x000D_ <tr>_x000D_ <td width="140">Related Products</td>_x000D_ <td width="633"><a href="https://moleculardepot.com/product-category/buffers/">Biochemical Buffers and Solutions</a></td>_x000D_ </tr>_x000D_ </tbody>_x000D_ </table>